Free Trial

Arcus Biosciences (RCUS) Short Interest Ratio & Short Volume

$16.12
-0.16 (-0.98%)
(As of 05/24/2024 ET)

Arcus Biosciences Short Interest Data

Current Short Interest
7,750,000 shares
Previous Short Interest
6,840,000 shares
Change Vs. Previous Month
+13.30%
Dollar Volume Sold Short
$118.11 million
Short Interest Ratio
10.3 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
90,950,000 shares
Float Size
47,380,000 shares
Short Percent of Float
16.36%
Today's Trading Volume
560,498 shares
Average Trading Volume
606,470 shares
Today's Volume Vs. Average
92%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Arcus Biosciences ?

Sign up to receive the latest short interest report for Arcus Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RCUS Short Interest Over Time

RCUS Days to Cover Over Time

RCUS Percentage of Float Shorted Over Time

Arcus Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20247,750,000 shares $118.11 million +13.3%16.4%10.3 $15.24
4/15/20246,840,000 shares $111.42 million -17.1%14.5%8.3 $16.29
3/31/20248,250,000 shares $155.76 million +3.4%17.4%9.7 $18.88
3/15/20247,980,000 shares $151.78 million +3.9%16.9%9.3 $19.02
2/29/20247,680,000 shares $146.92 million +2.1%16.2%8.6 $19.13
2/15/20247,520,000 shares $123.37 million +7.4%15.9%8.6 $16.41
1/31/20247,000,000 shares $105.91 million -2.1%22.3%8.7 $15.13
1/15/20247,150,000 shares $125.20 million -1.7%14.8%9.1 $17.51
12/31/20237,270,000 shares $138.86 million +7.4%15.1%9.6 $19.10
12/15/20236,770,000 shares $122.67 million +2.9%14.0%8.6 $18.12
11/30/20236,580,000 shares $99.09 million +9.3%13.7%9.1 $15.06
11/15/20236,020,000 shares $87.59 million -13.0%12.5%7.8 $14.55
10/31/20236,920,000 shares $108.68 million +0.6%14.4%8.3 $15.71
10/15/20236,880,000 shares $110.91 million +3.9%14.4%8.7 $16.12
9/30/20236,620,000 shares $118.83 million +1.4%13.8%8 $17.95
9/15/20236,530,000 shares $134.39 million -11.0%13.6%8 $20.58
8/31/20237,340,000 shares $150.47 million +2.5%15.5%7.4 $20.50
8/15/20237,160,000 shares $128.67 million -1.1%15.1%6.6 $17.97
7/31/20237,240,000 shares $144.08 million -6.7%15.2%6.8 $19.90
7/15/20237,760,000 shares $169.94 million -1.7%16.7%7.2 $21.90
6/30/20237,890,000 shares $160.25 million -18.1%16.9%7.3 $20.31
6/15/20239,630,000 shares $188.75 million -6.0%20.2%9 $19.60
5/31/202310,240,000 shares $210.33 million +18.0%21.5%9.6 $20.54
5/15/20238,680,000 shares $169.43 million +11.1%18.3%9 $19.52
4/30/20237,810,000 shares $139.41 million -3.2%16.6%8.4 $17.85
4/15/20238,070,000 shares $141.55 million +5.1%17.1%8.4 $17.54
3/31/20237,680,000 shares $140.08 million +15.1%16.4%7.6 $18.24
3/15/20236,670,000 shares $113.12 million -10.7%14.2%5.5 $16.96
2/28/20237,470,000 shares $136.03 million +14.8%15.9%6.4 $18.21
2/15/20236,510,000 shares $127.92 million +0.6%14.0%5.6 $19.65
1/31/20236,470,000 shares $139.95 million +1.3%14.0%5.5 $21.63
1/15/20236,390,000 shares $130.23 million -12.8%13.7%5.3 $20.38
12/30/20227,330,000 shares $151.58 million -2.5%15.7%6.6 $20.68
12/15/20227,520,000 shares $233.12 million -0.5%16.1%7.6 $31.00
11/30/20227,560,000 shares $265.89 million +7.7%16.2%9.6 $35.17
11/15/20227,020,000 shares $210.95 million +4.8%15.1%10.3 $30.05
10/31/20226,700,000 shares $170.72 million -19.1%15.0%9.8 $25.48
10/15/20228,280,000 shares $220.58 million +1.4%18.6%13 $26.64
9/30/20228,170,000 shares $213.73 million -3.1%18.3%12.8 $26.16
9/15/20228,430,000 shares $226.43 million -0.5%18.9%12.6 $26.86
Discover AI Giants? (Ad)

Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Download Your Free Report Now]
8/31/20228,470,000 shares $203.96 million +3.2%19.0%12.1 $24.08
8/15/20228,210,000 shares $229.88 million +4.7%18.4%10.5 $28.00
7/31/20227,840,000 shares $208.47 million +5.0%19.6%7.6 $26.59
7/15/20227,470,000 shares $216.93 million +4.5%17.0%7 $29.04
6/30/20227,150,000 shares $181.18 million +4.5%16.2%6.5 $25.34
6/15/20226,840,000 shares $148.15 million -2.8%15.5%4.8 $21.66
5/31/20227,040,000 shares $133.41 million -11.7%16.0%5.3 $18.95
5/15/20227,970,000 shares $154.38 million -14.9%18.1%6 $19.37
4/30/20229,370,000 shares $226.85 million +10.8%21.0%8.8 $24.21
4/15/20228,460,000 shares $270.55 million +48.2%19.0%8.5 $31.98
3/31/20225,710,000 shares $180.21 million +5.6%12.9%5.7 $31.56
3/15/20225,410,000 shares $171.23 million -5.6%12.1%8.3 $31.65
2/28/20225,730,000 shares $213.16 million -1.4%12.9%8.3 $37.20
2/15/20225,810,000 shares $172.56 million -4.4%13.2%8.6 $29.70
1/31/20226,080,000 shares $187.26 million -8.7%15.2%8.3 $30.80
1/15/20226,660,000 shares $238.49 million -20.6%15.8%9.6 $35.81
12/31/20218,390,000 shares $339.54 million +18.5%19.9%13.3 $40.47
12/15/20217,080,000 shares $286.88 million -5.2%16.8%10.9 $40.52
11/30/20217,470,000 shares $327.19 million +1.1%17.6%12.4 $43.80
11/15/20217,390,000 shares $281.34 million No Change17.4%13.3 $38.07
10/29/20217,390,000 shares $247.12 million +1.9%17.1%16.5 $33.44
10/15/20217,250,000 shares $249.33 million +2.1%16.8%16.1 $34.39
9/30/20217,100,000 shares $247.58 million -4.8%16.5%14.1 $34.87
9/15/20217,460,000 shares $248.94 million -2.7%17.4%11.6 $33.37
8/31/20217,670,000 shares $223.73 million -0.8%18.0%12.1 $29.17
8/13/20217,730,000 shares $211.57 million -0.9%18.1%11.7 $27.37
7/30/20217,800,000 shares $245.00 million +8.5%18.4%11.1 $31.41
7/15/20217,190,000 shares $205.49 million +6.2%17.0%10.1 $28.58
6/30/20216,770,000 shares $185.90 million +4.3%16.0%9.8 $27.46
6/15/20216,490,000 shares $158.03 million +0.3%15.3%10.4 $24.35
5/28/20216,470,000 shares $160.59 million +5.2%15.3%12.3 $24.82
5/14/20216,150,000 shares $170.05 million +11.4%14.5%11.8 $27.65
4/30/20215,520,000 shares $184.48 million -3.0%13.1%10.3 $33.42
4/15/20215,690,000 shares $188.96 million -6.7%13.5%10.9 $33.21
3/31/20216,100,000 shares $171.17 million +3.6%14.5%11.4 $28.06
3/15/20215,890,000 shares $214.69 million No Change14.0%11.1 $36.45
2/26/20215,890,000 shares $201.73 million -0.2%14.9%11.5 $34.25
2/12/20215,900,000 shares $218.30 million -1.5%16.3%11.9 $37.00
1/29/20215,990,000 shares $212.11 million -5.2%16.5%12.6 $35.41
1/15/20216,320,000 shares $245.41 million +7.5%15.1%12.1 $38.83
12/31/20205,880,000 shares $159.64 million -6.8%13.9%11.7 $27.15
12/15/20206,310,000 shares $202.61 million -2.2%14.9%13 $32.11
11/30/20206,450,000 shares $165.83 million -2.9%15.2%12.4 $25.71
11/15/20206,640,000 shares $150.06 million -2.5%15.7%12.6 $22.60
10/30/20206,810,000 shares $159.49 million -2.9%16.1%12.1 $23.42
10/15/20207,010,000 shares $137.19 million +8.4%17.3%13.8 $19.57
9/30/20206,470,000 shares $110.90 million +19.8%16.5%12.3 $17.14
9/15/20205,400,000 shares $114.53 million +3.5%13.7%8.9 $21.21
8/31/20205,220,000 shares $124.24 million +3.6%13.3%8.3 $23.80
8/14/20205,040,000 shares $119.85 million +13.0%14.1%6.5 $23.78
Discover AI Giants? (Ad)

Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Download Your Free Report Now]
7/31/20204,460,000 shares $87.77 million +7.7%13.2%5.6 $19.68
7/15/20204,140,000 shares $96.83 million +23.2%13.9%5 $23.39
6/30/20203,360,000 shares $79.40 million +101.2%8.9%3.7 $23.63
6/15/20201,670,000 shares $46.46 million +9.2%4.4%2 $27.82
5/29/20201,530,000 shares $47.97 million +260.0%4.6%2.1 $31.35
5/15/2020425,000 shares $14.89 million +28.2%1.6%0.7 $35.03
4/30/2020331,600 shares $8.76 million -50.7%1.2%0.6 $26.41
4/15/2020672,900 shares $10.48 million -7.8%2.5%1.4 $15.58
3/31/2020730,000 shares $21.17 million -23.0%2.7%2.3 $29.00
3/13/2020948,200 shares $15.10 million -37.6%2.9%3.8 $15.93
2/28/20201,520,000 shares $15.96 million +22.6%5.6%6.1 $10.50
2/14/20201,240,000 shares $21.74 million -3.9%4.6%6.3 $17.53
1/31/20201,290,000 shares $19.69 million -9.8%4.5%10.3 $15.26
1/15/20201,430,000 shares $16.42 million No Change5.0%12.9 $11.48
12/31/20191,430,000 shares $13.41 million -1.4%5.0%8.9 $9.38
8/15/20191,586,200 shares $10.58 million -1.4%6.2%8.8 $6.67

RCUS Short Interest - Frequently Asked Questions

What is Arcus Biosciences' current short interest?

Short interest is the volume of Arcus Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 7,750,000 shares of RCUS short. 16.36% of Arcus Biosciences' shares are currently sold short. Learn More on Arcus Biosciences' current short interest.

What is a good short interest ratio for Arcus Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCUS shares currently have a short interest ratio of 10.0. Learn More on Arcus Biosciences's short interest ratio.

Which institutional investors are shorting Arcus Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arcus Biosciences: Walleye Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Arcus Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.36% of Arcus Biosciences' floating shares are currently sold short.

Is Arcus Biosciences' short interest increasing or decreasing?

Arcus Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 7,750,000 shares, an increase of 13.3% from the previous total of 6,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Arcus Biosciences' float size?

Arcus Biosciences currently has issued a total of 90,950,000 shares. Some of Arcus Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcus Biosciences currently has a public float of 47,380,000 shares.

How does Arcus Biosciences' short interest compare to its competitors?

16.36% of Arcus Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Arcus Biosciences: Ligand Pharmaceuticals Incorporated (4.42%), Supernus Pharmaceuticals, Inc. (9.16%), Avadel Pharmaceuticals plc (4.99%), Taro Pharmaceutical Industries Ltd. (0.68%), Schrödinger, Inc. (9.65%), Dynavax Technologies Co. (14.99%), Morphic Holding, Inc. (12.82%), Xencor, Inc. (10.83%), Structure Therapeutics Inc. (10.35%), Edgewise Therapeutics, Inc. (10.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Arcus Biosciences stock?

Short selling RCUS is an investing strategy that aims to generate trading profit from Arcus Biosciences as its price is falling. RCUS shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Arcus Biosciences?

A short squeeze for Arcus Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RCUS, which in turn drives the price of the stock up even further.

How often is Arcus Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCUS, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:RCUS) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners